CSPC Pharmaceutical Group Ltd.

Products

Category

Product

Brand

Description

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023 (PHM263B)

Finished Drugs		NBP (Butylphthalide): Available in soft capsules and injections, NBP is used for the treatment of ischemic stroke., Oulaining (Oxiracetam): Offered in capsules and lyophilized powder for injections, Oulaining is utilized for cognitive disorders., Enxi (Enalapril Maleate): A medication for hypertension and heart failure., Debixin (Dibazole): Used as a vasodilator to manage hypertension., Qimaite (Meglumine Adenosine Cyclophosphate): Employed in the treatment of cardiovascular diseases.
Bulk Drugs		Vitamin C Series: CSPC is a leading producer of Vitamin C products., Antibiotics: Production of various antibiotic active pharmaceutical ingredients (APIs)., Caffeine Series: Manufacturing of caffeine and related products.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment